Recurrent very late stent thrombosis in a systemic lupus erythematous patient

Korean Circulation Journal

Volumn 42, Issue 2, 2012, Pages 118-121

  Lee, Dong Yob ^a   Park, Jong Pil ^a   Ko, Sung Jun ^a   Lee, Shin Eun ^a   Jhon, Sung Hee ^a   Lim, Ji Hyun ^a   Rhew, Jay Young ^a  

^a Presbyterian Medical Center   (South Korea)

Author keywords

Drug eluting stents; Lupus erythematosus; Systemic

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; PREDNISOLONE; QUINOLONE DERIVATIVE;

ADULT; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTERY OCCLUSION; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOTTING PARAMETERS; BRONCHIAL ARTERY; CASE REPORT; CORONARY ARTERY DISEASE; DRUG DOSE INCREASE; DRUG ELUTING STENT; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HEMOPTYSIS; HOSPITAL DISCHARGE; HUMAN; INTRAVASCULAR ULTRASOUND; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 84863258641     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.2.118     Document Type: Article

References (13)

1. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematous: quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981;70:775-81. (Pubitemid 11057007)
2. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406. (Pubitemid 37542988)
3. Metha PK, Samday H, Vassiliades TA, Book WM. Acute coronary syndrome as a first presentation of systemic lupus erythematosus in a teenager: revascularization by hybrid coronary artery bypass graft surgery and percutaneous coronary intervention: case report. Pediatr Cardiol 2008;29:957-61.
4. Kassaian S, Goodarzynejad H, Darabian S, Basiri Z. Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematous. Cardiovas J Afr 2008;19:152-4.
5. Lee CH, Chong E, Low A, Um J, Lme YT, Tan HC. Long-term follow-up after percutaneous coronary intervention in patients with systemic lupus erythematous. Int J Cardiol 2008;126:430-2. (Pubitemid 351636347)
6. Lee CH, Chan MY. Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus. Int J Cardiol 2007;114:e107-8. (Pubitemid 44855933)
7. Olivier AC, Hollman JL Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin. J Invasive Cardiol 2006;18:E185-7. (Pubitemid 44680991)
8. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. (Pubitemid 37229465)
9. Moon YG, Kim YJ, Jeon DS, et al. A case of premature coronary atherosclerosis associated with systemic lupus erythematosus. Korean Circ J 1995;25:691-7.
10. Muir DF, Stevens A, Napier-Hemy RO, Fath-Ordoubadi F, Curzen N. Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma. IntJ Cardiovasc Intervent 2003;5:44-6. (Pubitemid 36227315)
11. Su HM, Lee KT, Chu CS, Sheu SH, Lai WT. Acute thrombosis after elective direct intracoronary stenting in primary antiphospholipid syndrome: a case report. Kaohsiung J Med Sci 2003;19:177-82.
12. Lee KH, Lee SW, Lee JW, et al. The significance of Clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation. Korean Circ J 2009;39:512-8.
13. Lee CW, Kang SJ, Park DW, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1943-4.